1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 29)
4.1 Lucrative Opportunities in the Global Genome Editing Market
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Application
5.2.2 By Product
5.2.3 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increased R&D Expenditure and Growth of the Biotechnology and Pharmaceutical Industries
5.3.1.2 Increased Funding for Genomics Research
5.3.1.3 Technological Advancements
5.3.1.4 Increasing Demand for Synthetic Genes
5.3.1.5 Global Rise in Production of Genetically Modified Crops
5.3.2 Restraints
5.3.2.1 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
5.3.2.2 Adverse Public Perception Related to Genetic Research
5.3.3 Opportunities
5.3.3.1 Developing Countries
5.3.4 Challenges
5.3.4.1 Off-Target Effect of Crispr

6 Industry Insights (Page No. – 42)
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat From New Entrants
6.2.2 Threat From Substitutes
6.2.3 Bargaining Power of Buyers
6.2.4 Bargaining Power of Suppliers
6.2.5 Intensity of Rivalry
6.3 Strategic Benchmarking
6.4 Supply Chain Analysis
6.4.1 Key Influencers

7 Genome Editing Market, By Application (Page No. – 46)
7.1 Introduction
7.2 Cell Line Engineering
7.3 Animal Genetic Engineering
7.4 Plant Genetic Engineering
7.5 Other Applications

8 Genome Editing Market, By Technology (Page No. – 58)
8.1 Introduction
8.2 Crispr
8.3 Talen
8.4 ZFN
8.5 Antisense Technology
8.6 Other Technologies

9 Genome Editing Market, By End User (Page No. – 71)
9.1 Introduction
9.2 Biotechnology & Pharmaceutical Companies
9.3 Academic & Government Research Institutes
9.4 Contract Research Organizations

10 Geographic Analysis (Page No. – 81)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 120)
11.1 Overview
11.2 Leading Players in the Genome Editing Market
11.3 Competitive Situation and Trends
11.3.1 Agreements, Collaborations, and Partnerships
11.3.2 New Product and Service Launches
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Developments

12 Company Profiles (Page No. – 129)
12.1 Introduction
12.2 Thermo Fisher Scientific, Inc.
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Recent Developments
12.2.4 MnM View
12.2.4.1 Financial Analysis
12.2.4.2 Strategic Analysis
12.3 Horizon Discovery Group Plc
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Recent Developments
12.3.4 MnM View
12.3.4.1 Strategic Analysis
12.4 Sigma-Aldrich Corporation
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Recent Developments
12.4.4 MnM View
12.4.4.1 Financial Analysis
12.4.4.2 Strategic Analysis
12.5 Genscript USA Inc.
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Recent Developments
12.5.4 MnM View
12.5.4.1 Strategic Analysis
12.6 Sangamo Biosciences, Inc.
12.6.1 Business Overview
12.6.2 Product Portfolio
12.6.3 Recent Developments
12.6.4 MnM View
12.6.4.1 Strategic Analysis
12.7 Integrated Dna Technologies, Inc.
12.7.1 Business Overview
12.7.2 Product Portfolio
12.7.3 Recent Developments
12.7.4 Key Strategy
12.8 Lonza Group Ltd. (Switzerland)
12.8.1 Business Overview
12.8.2 Product Portfolio
12.9 New England Biolabs, Inc. (U.S.)
12.9.1 Business Overview
12.9.2 Product Portfolio
12.10 Origene Technologies, Inc. (U.S.)
12.10.1 Business Overview
12.10.2 Product Portfolio
12.10.3 Recent Developments
12.10.4 Key Strategy
12.11 Transposagen Biopharmaceuticals, Inc. (U.S.).
12.11.1 Business Overview
12.11.2 Product Portfolio
12.11.3 Recent Developments
12.11.4 Key Strategy

13 Appendix (Page No. – 154)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports

List of Tables (83 Tables)

Table 1 Genome Editing Market Summary
Table 2 Rapid Growth in the Pharmaceutical and Biotechnology Industries is Driving the Genome Engineering Market
Table 3 Stringent Regulatory Frameworks and Adverse Public Perception Related to Genetic Research Restrain the Growth of the Genome Editing Market
Table 4 Developing Countries Present Significant Growth Opportunities
Table 5 Off-Target Effect of Crispr is A Major Challenge for Market Players
Table 6 Market Developments Between 2011 and 2014
Table 7 Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 8 Genome Engineering Market Size for Cell Line Engineering, By Region, 2012–2019 ($Million)
Table 9 North America: Genome Editing Market Size for Cell Line Engineering, By Country, 2012–2019 ($Million)
Table 10 Asia: Genome Engineering Market Size for Cell Line Engineering, By Country, 2012–2019 ($Million)
Table 11 Genome Engineering Market Size for Animal Genetic Engineering, By Region, 2012–2019 ($Million)
Table 12 North America: Genome Engineering Market Size for Animal Genetic Engineering, By Country, 2012–2019 ($Million)
Table 13 Asia: Genome Editing Market Size for Animal Genetic Engineering, By Country, 2012–2019 ($Million)
Table 14 Genome Engineering Market Size for Plant Genetic Engineering, By Region, 2012-2019 ($Million)
Table 15 North America: Genome Engineering Market Size for Plant Genetic Engineering, By Country, 2012–2019 ($Million)
Table 16 Asia: Genome Engineering Market Size for Plant Genetic Engineering, By Region, 2012–2019 ($Million)
Table 17 Genome Editing Market Size for Other Applications, By Region, 2012-2019 ($Million)
Table 18 North America: Genome Editing Market Size for Other Applications, By Country, 2012–2019 ($Million)
Table 19 Asia: Genome Engineering Market Size for Other Applications, By Country, 2012–2019 ($Million)
Table 20 Genome Engineering Market Size, By Technology, 2012–2019 ($Million)
Table 21 Crispr-Based Genome Editing Market Size, By Region, 2012–2019 ($Million)
Table 22 North America: Crispr-Based Genome Editing Market Size, By Country, 2012–2019 ($Million)
Table 23 Asia: Crispr-Based Genome Editing Market Size, By Country, 2012–2019 ($Million)
Table 24 Talen-Based Genome Engineering Market Size, By Region, 2012–2019 ($Million)
Table 25 North America: Talen-Based Genome Editing Market Size, By Country, 2012–2019 ($Million)
Table 26 Asia: Talen-Based Genome Engineering Market Size, By Country, 2012–2019 ($Million)
Table 27 ZFN-Based Genome Editing Market Size, By Region, 2012–2019 ($Million)
Table 28 North America: ZFN-Based Genome Editing Market Size, By Country, 2012–2019 ($Million)
Table 29 Asia: ZFN-Based Genome Engineering Market Size, By Country, 2012–2019 ($Million)
Table 30 Antisense Technology-Based Genome Engineering Market Size, By Region, 2012–2019 ($Million)
Table 31 North America: Antisense-Based Genome Engineering Market Size, By Country, 2012–2019 ($Million)
Table 32 Asia: Antisense-Based Genome Editing Market Size, By Country, 2012–2019 ($Million)
Table 33 Other Technology-Based Genome Engineering Market Size, By Region, 2012–2019 ($Million)
Table 34 North America: Other Technology-Based Genome Engineering Market Size, By Country, 2012–2019 ($Million)
Table 35 Asia: Other Technology-Based Genome Editing Market Size, By Country, 2012–2019 ($Million)
Table 36 Global Genome Engineering Market Size, By End User, 2012–2019 ($Million)
Table 37 Global Genome Engineering Market Size for Biotechnology & Pharmaceutical Companies, By Region, 2012–2019 ($Million)
Table 38 North America: Genome Editing Market Size for Biotechnology & Pharmaceutical Companies, By Country, 2012–2019 ($Million)
Table 39 Asia: Genome Engineering Market Size for Biotechnology & Pharmaceutical Companies, By Country, 2012–2019 ($Million)
Table 40 Global Genome Editing Market Size for Academic and Government Research Institutes, By Region, 2012–2019 ($Million)
Table 41 North America: Genome Engineering Market Size for Academic & Government Research Institutes, By Country, 2012–2019 ($Million)
Table 42 Asia: Genome Editing Market Size for Academic & Government Research Institutes, By Country, 2012–2019 ($Million)
Table 43 Global Genome Engineering Market Size for Contract Research Organizations, By Region, 2012–2019 ($Million)
Table 44 North America: Genome Engineering Market Size for Contract Research Organizations, By Country, 2012–2019 ($Million)
Table 45 Asia: Genome Editing Market Size for Contract Research Organizations, By Country, 2012–2019 ($Million)
Table 46 Genome Editing Market Size, By Region, 2012–2019 ($Million)
Table 47 North America: Genome Editing Market Size, By Region, 2012–2019 ($Million)
Table 48 North America: Genome Engineering Market Size, By Application, 2012–2019 ($Million)
Table 49 North America: Genome Engineering Market Size, By Technology, 2012–2019 ($Million)
Table 50 North America: Genome Engineering Market Size, By End User, 2012–2019 ($Million)
Table 51 U.S.: Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 52 U.S.: Market Size, By Technology, 2012–2019 ($Million)
Table 53 U.S.: Market Size, By End User, 2012–2019 ($Million)
Table 54 Canada: Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 55 Canada: Market Size, By Technology, 2012–2019 ($Million)
Table 56 Canada: Genome Engineering Market Size, By End User, 2012–2019 ($Million)
Table 57 Europe: Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 58 Europe: Market Size, By Technology, 2012–2019 ($Million)
Table 59 Europe: Market Size, By End User, 2012–2019 ($Million)
Table 60 Asia: Genome Editing Market Size, By Country, 2012–2019 ($Million)
Table 61 Asia: Market Size, By Application, 2012–2019 ($Million)
Table 62 Asia: Market Size, By Technology, 2012–2019 ($Million)
Table 63 Asia: Genome Engineering Market Size, By End User, 2012–2019 ($Million)
Table 64 Japan: Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 65 Japan: Market Size, By Technology, 2012–2019 ($Million)
Table 66 Japan: Market Size, By End User, 2012–2019 ($Million)
Table 67 China: Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 68 China: Market Size, By Technology, 2012–2019 ($Million)
Table 69 China: Genome Engineering Market Size, By End User, 2012–2019 ($Million)
Table 70 India: Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 71 India: Market Size, By Technology, 2012–2019 ($Million)
Table 72 India: Market Size, By End User, 2012–2019 ($Million)
Table 73 RoA: Genome Editing Market Size, By Application, 2012–2019 ($Million)
Table 74 RoA: Market Size, By Technology, 2012–2019 ($Million)
Table 75 RoA: Market Size, By End User, 2012–2019 ($Million)
Table 76 RoW: Market Size, By Application, 2012–2019 ($Million)
Table 77 RoW: Market Size, By Technology, 2012–2019 ($Million)
Table 78 RoW: Genome Engineering Market Size, By End User, 2012–2019 ($Million)
Table 79 Rank of Companies in the Global Genome Editing Market, 2014
Table 80 New Product and Service Launches, 2012–2015
Table 81 Acquisitions, 2012–2015
Table 82 Expansions, 2012–2015
Table 83 Other Developments, 2012–2015

List of Figures (91 Figures)

Figure 1 Genome Editing Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Genome Editing Market Size, By Application, 2014 vs. 2019 ($Million)
Figure 8 Genome Engineering Market Size, By Technology, 2014 vs. 2019 ($Million)
Figure 9 Genome Engineering Market Size, By End User, 2014 vs. 2019 ($Million)
Figure 10 Market Size, By Region, 2014 vs. 2019 ($Million)
Figure 11 Increase in Pharmaceutical and Biotechnology Industries Will Drive Market Growth
Figure 12 Animal Genetic Engineering Application Segment Accounted for the Largest Market Share in 2014
Figure 13 Asian Market to Experience Fastest Growth in the Forecast Period (2014 to 2019)
Figure 14 Asia Poised for Lucrative Growth
Figure 15 Genome Editing Market Segmentation: By Application
Figure 16 Genome Engineering Market Segmentation: By Technology
Figure 17 Genome Engineering Market Segmentation: By End User
Figure 18 Growth in Pharmaceutical and Biotechnology Industries Will Drive the Genome Editing Market
Figure 19 High Capital Investments to Restrict the Entry of New Players
Figure 20 Direct Distribution Strategy Preferred By Prominent Companies
Figure 21 Genome Editing Market Segmentation, By Application
Figure 22 Genome Engineering Market Size, By Application, 2014 vs. 2019 ($Million)
Figure 23 Cell Line Engineering Will Be the Fastest-Growing Application Segment of the Genome Editing Market
Figure 24 North America Dominated the Animal Genetic Engineering Application Segment in 2014
Figure 25 Growing Trend of GM Crops in the U.S.
Figure 26 Asia to Witness Highest Growth in the Plant Genetic Engineering Application Segment
Figure 27 Asia to Witness Highest Growth in the Other Applications Segment
Figure 28 Genome Editing Market Segmentation, By Technology
Figure 29 Market Size, By Technology, 2014 vs. 2019 ($Million)
Figure 30 North America to Command the Largest Share of the Crispr Segment in 2019
Figure 31 North America to Dominate the Talen Segment in 2019
Figure 32 Asia Will Be the Fastest-Growing Regional Segment for ZFN in 2019
Figure 33 North America Was the Biggest Market for Antisense Technology in 2014
Figure 34 Asia Will Be the Fastest-Growing Market for Other Technologies Between 2014 and 2019
Figure 35 Genome Editing Market Segmentation, By End User
Figure 36 Biotechnology and Pharmaceutical Companies Were the Largest End-User Segment in 2014
Figure 37 Number of Biotechnology and Pharmaceutical Patents Granted in 2012, By Region
Figure 38 Biotechnology & Pharmaceutical Companies End-User Segment to Witness the Highest Growth in Asia
Figure 39 Public-Sector Research Funding is Driving the Growth of the Academic & Government Research Institutes Segment
Figure 40 North America Dominated the Genome Editing Market for Academic & Government Research Institutes
Figure 41 Asia to Witness the Highest Growth in the Genome Editing Market for Contract Research Organizations
Figure 42 Genome Editing Market Segmentation, By Region
Figure 43 Market, By Region (Market Size and Growth Rate), 2014–2019
Figure 44 Market in Asia Expected to Grow at the Highest Rate From 2014 to 2019
Figure 45 North America: Market Snapshot
Figure 46 North America: Genome Editing Market, By Region (Market Size and Growth Rate), 2014-2019
Figure 47 Cell Line Engineering Held the Largest Share of the Genome Editing Market in North America in 2014
Figure 48 Crispr Formed the Largest Technology Segment in North America
Figure 49 Biotechnology and Pharmaceutical Companies Formed the Largest End-User Segment in North America in 2014
Figure 50 Cell Line Engineering Formed the Largest Application Segment in the U.S.
Figure 51 Crispr Technology Segment Held the Largest Share in the U.S. Market
Figure 52 Biotechnology and Pharmaceutical Companies Segment Dominated the U.S. Market
Figure 53 Cell Line Engineering Held the Largest Share in the Genome Editing Applications Market in Canada
Figure 54 Crispr Formed the Largest Technology Segment in Canada
Figure 55 Biotechnology and Pharmaceutical Companies Formed the Largest End-User Segment in Canada in 2014
Figure 56 Cell Line Engineering Accounted for the Largest Share of the Genome Editing Applications Market in Europe
Figure 57 Crispr Formed the Largest Technology Segment in Europe in 2014
Figure 58 Biotechnology and Pharmaceutical Companies Accounted for the Largest Share of the Genome Editing Market in Europe
Figure 59 Asia: Market Snapshot
Figure 60 Asia: Genome Editing Market, By Country (Market Size and Growth Rate)
Figure 61 Cell Line Engineering Segment Dominated the Genome Editing Applications Market in Asia
Figure 62 Crispr Segment Accounted for the Largest Share of the Genome Editing Technologies Market in Asia
Figure 63 Biotechnology and Pharmaceutical Companies Accounted for the Largest Share of the Genome Editing Market in Asia
Figure 64 Cell Line Engineering Formed the Largest Application Segment in Japan
Figure 65 Crispr Technology Segment Held the Largest Share of the Market in Japan
Figure 66 Biotechnology and Pharmaceutical Companies Accounted for the Largest Share of the Genome Editing End-Users Market in Japan
Figure 67 Cell Line Engineering Was the Largest Application Segment in China in 2014
Figure 68 Crispr Held the Largest Share of the Market in China
Figure 69 Biotechnology and Pharmaceutical Companies Accounted for the Largest Share of the Genome Engineering Market in China
Figure 70 Cell Line Engineering Formed the Largest Application Segment in India
Figure 71 Crispr Formed the Largest and the Fastest-Growing Technology Segment in India
Figure 72 Biotechnology and Pharmaceutical Companies Formed the Largest End-User Segment in India
Figure 73 Cell Line Engineering Commanded the Largest Share of the RoA Genome Editing Market in 2014
Figure 74 Crispr Technology Segment Dominated the RoA Market for Genome Editing
Figure 75 Biotechnology and Pharmaceutical Companies Segment Dominate the RoA Market for Genome Editing
Figure 76 Cell Line Engineering Commanded the Largest Share of the RoW Genome Engineering Applications Market
Figure 77 Crispr Were the Largest Technology Segment in 2014
Figure 78 Biotechnology and Pharmaceutical Companies Segment Dominate the RoW Market for Genome EngineeringFigure 79 Players Adopted Agreements, Collaborations, and Partnerships as Their Key Strategy
Figure 80 Battle for Market Share: Agreements, Collaborations, and Partnerships Was the Key Strategy
Figure 81 Agreements, Collaborations, and Partnerships, 2012–2015
Figure 82 Agreements, Collaborations, and Partnerships, 2012–2015
Figure 83 New Product and Service Launches, 2012–2015
Figure 84 Acquisitions, 2012–2015
Figure 85 Expansions, 2012–2015
Figure 86 Other Developments, 2012–2015
Figure 87 Geographic Revenue Mix of the Top Five Market Players
Figure 88 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 89 Sigma-Aldrich Corporation: Company Snapshot
Figure 90 Sangamo Biosciences, Inc.: Company Snapshot
Figure 91 Lonza Group Ltd.: Company Snapshot

【レポートのキーワード】

ゲノム編集（ゲノム工学）、細胞株工学、動物遺伝子工学、植物遺伝子工学、ゲノム編集技術、遺伝子、CRISPR、バイオ技術